Double-negative T cells ameliorate psoriasis by selectively inhibiting IL-17A-producing γδlow T cells

Yunxiong Wei,Guangyong Sun,Yang Yang,Mingyang Li,Shimeng Zheng,Xiyu Wang,Xinjie Zhong,Zihan Zhang,Xiaotong Han,Haiyan Cheng,Dong Zhang,Xueling Mei
DOI: https://doi.org/10.1186/s12967-024-05132-8
IF: 8.44
2024-04-05
Journal of Translational Medicine
Abstract:Psoriasis is a chronic immune-mediated skin condition. Although biologic treatments are effective in controlling psoriasis, some patients do not respond or lose response to these therapies. Thus, new strategies for psoriasis treatment are still urgently needed. Double-negative T cells (DNT) play a significant immunoregulatory role in autoimmune diseases. In this study, we aimed to evaluate the protective effect of DNT in psoriasis and explore the underlying mechanism.
medicine, research & experimental
What problem does this paper attempt to address?